DIAGENS-B's stock surged 5.60% during intraday trading on Monday, reflecting strong investor confidence in the company's latest financial performance.

The significant price increase was primarily driven by the company's recently disclosed first-quarter results, which showed a substantial improvement in profitability that exceeded market expectations. DIAGENS-B reported Q1 net profit of 580 million yuan, representing a year-over-year increase of 12.3%.

As a health care equipment company, the strong earnings performance has continued to attract capital inflows, with the stock sustaining upward momentum on the back of improving fundamentals. This marks the second notable intraday surge this month, following a similar performance earlier in April.